Diabetic Neuropathy Treatment Market 2023 –Focused Research Report

Posted by vinit sawant on February 12th, 2021

Diabetic neuropathy is one of the most common complications of diabetes. Patients suffering from diabetic neuropathy often report burning pain in the foot. The rising prevalence of diabetic neuropathy can be seen worldwide. Around 83% of people in the US are suffering from diabetic neuropathy.

According to MRFR analysis, the global diabetic neuropathy treatment market is expected to register a CAGR of 5.1% during the forecast period of 2019 to 2025 and was valued at USD 5.80 Billion by 2025.

According to a Japanese study around 298 people were diagnosed with diabetic neuropathy in 2017. The growth of the global diabetic neuropathy treatment market is driven by various factors such as an increasing global geriatric population, rising prevalence of diabetes, and poor fitness levels. However, high costs of surgery are expected to curb the growth of the global diabetic neuropathy treatment market.

Segmentation

The global diabetic neuropathy treatment market has been segmented based on disorder, treatment, and end-user.

The market, based on disorder, has been divided into peripheral neuropathy, autonomic neuropathy, proximal neuropathy, and focal neuropathy. The peripheral neuropathy segment is likely to be the largest during the review period due to a growing aging population and increasing prevalence of peripheral neuropathy globally.